PB 99 of 2015
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2015 (No. 1)
National Health Act 1953
I, KAREN BINNEKAMP, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.
Dated          29     September 2015
 
 
 
 
 
 
 
 
 
 
 
KAREN BINNEKAMP
 
 
Assistant Secretary (Acting)
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
1              Name of Determination
       (1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2015 (No. 1).
       (2)     This Determination may also be cited as PB 99 of 2015.
2              Commencement
                This Determination commences on 1 October 2015.
 
 
3              Amendments to PB 1 of 2010
Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).
 
 
Schedule 1             Amendments
 
[12]    Schedule 1, Part 2
  omit:
 
6
Telmisartan